Aptorum files amended 8-K updating DiamiR Biosciences financial statementsPUBT·58 minutes agoAPM0.00%NIKI+4.63%
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% StakeTradingView·Jul 24 at 03:36 PMNIKI+4.63%APM0.00%
Niki BioSolutions falls 9% as gains fade after gene testing dealUS Stock Market Update·Jul 23 at 02:10 PMNIKI+4.63%
Niki BioSolutions falls 5% as early 44% surge fadesUS Stock Market Update·Jul 23 at 12:32 PMNIKI+4.63%
Niki BioSolutions climbs 2% on APOE testing deal after 44% premarket surgeUS Stock Market Update·Jul 23 at 09:00 AMNIKI+4.63%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC+12.95%HYFT+2.92%
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.benzinga_article·Jul 23 at 07:04 AMNIKI+4.63%
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)Unusual Whales·Jul 23 at 07:03 AMNIKI+4.63%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 12:05 PMTELO0.00%CPHI-7.55%
The Market's Misfits: Who is Faking It and Who is Building the Future?Global Report·Jul 21 at 04:13 AMCSIQ-1.22%AVEX+1.27%
Aptorum Group Provides Update on DiamiR Biosciences Merger | APM Stock NewsStockTitan·Jul 16 at 02:00 AMAPM0.00%NIKI+4.63%
Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutionsPUBT·Jul 8 at 07:04 AMAPM0.00%NIKI+4.63%
Aptorum amends 6-K to extend DiamiR merger termination date to July 31, 2026PUBT·Jun 22 at 04:01 PMAPM0.00%NIKI+4.63%